Torthaí cuardaigh - Subrat Kumar Acharya

Beachtaigh na torthaí
  1. 1
    Epidemiology of Hepatocellular Carcinoma in India

    Epidemiology of Hepatocellular Carcinoma in India de réir Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Hepatitis E and Acute Liver Failure in Pregnancy

    Hepatitis E and Acute Liver Failure in Pregnancy de réir S. Shalimar, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Management in Acute Liver Failure

    Management in Acute Liver Failure de réir S. Shalimar, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Epidemiology of hepatitis B virus infection in India.

    Epidemiology of hepatitis B virus infection in India. de réir B. N. Tandon, Subrat Kumar Acharya, A Tandon

    Foilsithe / Cruthaithe 1996
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Acute hepatic failure in India: A perspective from the East

    Acute hepatic failure in India: A perspective from the East de réir Subrat Kumar Acharya, Subrat Kumar Panda, Alka Saxena, Sudeep Gupta

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter

    Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter de réir Vaishali Chaudhuri, Ruchi Tayal, Baibaswata Nayak, Subrat Kumar Acharya, Subrat Kumar Panda

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Stem cell therapies in the clinic

    Stem cell therapies in the clinic de réir Subrat Kumar Acharya, Suyog Shaha, Michael Griffith Bibbey, Malini Mukherji, Zongmin Zhao, Samir Mitragotri

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis

    A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis de réir Payal Bhardwaj, Pramod Kumar Garg, Subir Kumar Maulik, Anoop Saraya, Rakesh K. Tandon, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction

    Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction de réir Shashi Bala Paul, S. Shalimar, Vishnubhatla Sreenivas, Shivanand Gamanagatti, Hanuman Prasad Sharma, Ekta Dhamija, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Antituberculosis therapy-induced acute liver failure: Magnitude, profile, prognosis, and predictors of outcome

    Antituberculosis therapy-induced acute liver failure: Magnitude, profile, prognosis, and predictors of outcome de réir Ramesh Kumar, S. Shalimar, Vikram Bhatia, Shankar Prasad Khanal, V. Sreenivas, Datta Gupta, Subrat Kumar Panda, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score

    Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score de réir S. Shalimar, Ashish Kumar, Saurabh Kedia, Hanuman Prasad Sharma, Shivanand Gamanagatti, Gunsagar S. Gulati, Baibaswata Nayak, Bhaskar Thakur, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study

    High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study de réir Ajay Duseja, Subrat Kumar Acharya, Manu Mehta, Shruti Chhabra, Satyavati Rana, Ashim Das, S Dattagupta, Radha K. Dhiman, Yogesh Chawla

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Toward an Improved Definition of Acute-on-Chronic Liver Failure

    Toward an Improved Definition of Acute-on-Chronic Liver Failure de réir Rajiv Jalan, Cihan Yurdaydın, Jasmohan S. Bajaj, Subrat Kumar Acharya, Vicente Arroyo, Han‐Chieh Lin, Pere Ginès, W. Ray Kim, Patrick S. Kamath

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Editorial
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Clinical Profile, Etiology and Therapeutic Outcome in 324 Hepatocellular Carcinoma Patients at a Tertiary Care Center in India

    Clinical Profile, Etiology and Therapeutic Outcome in 324 Hepatocellular Carcinoma Patients at a Tertiary Care Center in India de réir Shashi Bala Paul, Sreenivasa Baba Chalamalasetty, Vishnubhatla Sreenivas, Kaushal Madan, Shivanand Gamanagatti, Yogesh Batra, Siddhartha Dutta Gupta, Subrat Kumar Panda, Subrat Kumar Acharya

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection

    Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection de réir Swati Gupta, G. R. Rout, Arpan Patel, Mousumi Mahanta, Nidhi Kalra, Pabitra Sahu, Rahul Sethia, Ashish Agarwal, Gyan Ranjan, Saurabh Kedia, Subrat Kumar Acharya, Baibaswata Nayak, S. Shalimar

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens

    Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens de réir Masaya Sugiyama, Yasuhito Tanaka, Takanobu Kato, Etsuro Orito, Kiyoaki Ito, Subrat Kumar Acharya, Robert G. Gish, Anna Kramvis, Takashi Shimada, Namiki Izumi, Masahiko Kaito, Yuzo Miyakawa, Masashi Mizokami

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D

    A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D de réir Yasuhito Tanaka, Izumi Hasegawa, Takanobu Kato, Etsuro Orito, Noboru Hirashima, Subrat Kumar Acharya, Robert G. Gish, Anna Kramvis, Michael C. Kew, Namiko Yoshihara, Santosh Man Shrestha, Mobin Khan, Yuzo Miyakawa, Masashi Mizokami

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome

    Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome de réir Subrat Kumar Acharya, Srinivasan Dasarathy, T L Kumer, S Sushma, K. S. Prasanna, A Tandon, Vishnubhatla Sreenivas, Sandeep Nijhawan, Subrat Kumar Panda, Santosh Kumar Nanda, Mohammad Irshad, Yogesh Joshi, S Duttagupta, R. K. Tandon, B N Tandon

    Foilsithe / Cruthaithe 1996
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Etiology and mode of presentation of chronic liver diseases in India: A multi centric study

    Etiology and mode of presentation of chronic liver diseases in India: A multi centric study de réir Partha Sarathi Mukherjee, Vishnubhatla Sreenivas, Deepak Amarapurkar, Kausik Das, Ajit Sood, Yogesh Chawla, C. E. Eapen, Prabhakar Boddu, Varghese Thomas, Subodh Varshney, Diamond Sharma Hidangmayum, Pradip K. Bhaumik, Bhaskar Thakur, Subrat Kumar Acharya, Abhijit Chowdhury

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology

    Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of... de réir Ajay Duseja, Shivaram Prasad Singh, Vivek A. Saraswat, Subrat Kumar Acharya, Yogesh Chawla, Subhankar Chowdhury, Radha K. Dhiman, Rohinivilasam V. Jayakumar, Kaushal Madan, Sri P. Misra, Hrudananda Mishra, Sunil Modi, A Muruganathan, Banshi Saboo, Rakesh Sahay, Rajesh Kumar Upadhyay

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: